<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medecol</journal-id><journal-title-group><journal-title xml:lang="ru">Медицина и экология</journal-title><trans-title-group xml:lang="en"><trans-title>Medicine and ecology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-6045</issn><issn pub-type="epub">2305-6053</issn><publisher><publisher-name>Карагандинский медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.59598/ME-2305-6053-2025-116-3-108-129</article-id><article-id custom-type="elpub" pub-id-type="custom">medecol-1044</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТЕОРЕТИЧЕСКАЯ И ЭКСПЕРИМЕНТАЛЬНАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>THEORETICAL AND EXPERIMENTAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Сравнительная комплексная оценка применения различных объемообразующих наполнителей в урологии</article-title><trans-title-group xml:lang="en"><trans-title>COMPARATIVE COMPREHENSIVE ASSESSMENT OF THE USE OF VARIOUS VOLUME-FORMING FILLERS IN UROLOGY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аскаров</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Askarov</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>100008, г. Караганда, ул. Гоголя, 40</p></bio><bio xml:lang="en"><p>100008, Karaganda, Gogolya str., 40</p></bio><email xlink:type="simple">info@qmu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пак</surname><given-names>И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pak</surname><given-names>I. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>100008, г. Караганда, ул. Гоголя, 40</p></bio><bio xml:lang="en"><p>100008, Karaganda, Gogolya str., 40</p></bio><email xlink:type="simple">info@qmu.kz</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ескермесов</surname><given-names>Д. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Yeskermesov</surname><given-names>D. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дəурен Бахтиярұлы Ескермесов</p><p>100008, г. Караганда, ул. Гоголя, 40</p></bio><bio xml:lang="en"><p>Dauren Bakhtiyaruly Yeskermesov</p><p>100008, Karaganda, Gogolya str., 40</p></bio><email xlink:type="simple">eskermesov.dauren@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батенова</surname><given-names>У. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Batenova</surname><given-names>U. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>100008, г. Караганда, ул. Гоголя, 40</p></bio><bio xml:lang="en"><p>100008, Karaganda, Gogolya str., 40</p></bio><email xlink:type="simple">info@qmu.kz</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Клюев</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Klyuyev</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>100008, г. Караганда, ул. Гоголя, 40</p></bio><bio xml:lang="en"><p>100008, Karaganda, Gogolya str., 40</p></bio><email xlink:type="simple">info@qmu.kz</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Камышанский</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Kamyshanskiy</surname><given-names>Ye. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>100008, г. Караганда, ул. Гоголя, 40</p></bio><bio xml:lang="en"><p>100008, Karaganda, Gogolya str., 40</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Кафедра хирургических болезней НАО «Карагандинский медицинский университет»<country>Казахстан</country></aff><aff xml:lang="en">Department of Surgical Diseases of Karaganda Medical University NC JSC<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Институт наук о жизни НАО «Карагандинский медицинский университет»<country>Казахстан</country></aff><aff xml:lang="en">Institute of Life Sciences of Karaganda Medical University NC JSC<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">Патологоанатомический блок клиники НАО «Карагандинский медицинский университет»<country>Казахстан</country></aff><aff xml:lang="en">Pathological Anatomy Unit of the Clinic of Karaganda Medical University NC JSC<country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2025</year></pub-date><volume>0</volume><issue>3</issue><fpage>108</fpage><lpage>129</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Аскаров М.С., Пак И.L., Ескермесов Д.Б., Батенова У.Г., Клюев Д.А., Камышанский Е.К., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Аскаров М.С., Пак И., Ескермесов Д.Б., Батенова У.Г., Клюев Д.А., Камышанский Е.К.</copyright-holder><copyright-holder xml:lang="en">Askarov M.S., Pak I.L., Yeskermesov D.B., Batenova U.G., Klyuyev D.A., Kamyshanskiy Y.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medecol.qmu.kz/jour/article/view/1044">https://medecol.qmu.kz/jour/article/view/1044</self-uri><abstract><sec><title>Введение</title><p>Введение. Современная урология требует поиска и внедрения высокоэффективных и биосовместимых объемообразующих материалов, способных обеспечивать устойчивый клинический результат при минимальных рисках осложнений. Применение объемообразующих наполнителей приобретает особую значимость в реконструктивной и функциональной урологии, где важны как эстетические, так и функциональные параметры результата. На сегодняшний день используются различные синтетические и биологические материалы, однако каждый из них обладает определёнными ограничениями, связанными с резорбцией, иммуногенной реакцией и риском фиброзирования. В связи с этим актуальным направлением исследований является разработка и сравнительный анализ новых, комбинированных подходов, включающих в себя аутологические компоненты, обладающие высокой степенью биосовместимости.</p></sec><sec><title>Цель</title><p>Цель. Сравнительная комплексная оценка эффективности и биосовместимости различных объемообразующих наполнителей синтетического и аутологического происхождения, применяемых в урологической практике, с использованием морфологических и морфометрических методов анализа.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследовании использовали 80 самца бельгийских кроликов, которым проводили инъекцию 0,3 мл объемообразующего субстрата в подслизистый слой мочевого пузыря. Все случаи были разделены на пять групп. Через 14, 30 дней проводились гистологические, гистохимические, гистоморфометрические и морфометрические методы анализа для объективной оценки воспалительной реакции, васкуляризации, клеточной инфильтрации, степени фиброзирования и сохранности трансплантата.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Комбинация аутолипотрансплантата с PRP демонстрирует более выраженное формирование сосудистой сети, меньшую степень воспаления и более равномерное распределение трансплантированной ткани по сравнению с другими группами. Это указывает на высокую биосовместимость и потенциал данной комбинации как альтернативы синтетическим материалам, особенно в условиях, где требуется долговременный объемный эффект и минимальный риск осложнений.</p></sec><sec><title>Заключение</title><p>Заключение. Сочетание PRP с аутологичным липотрансплантатом, а также применение Vantris, представляются наиболее перспективными подходами для создания стабильного и биосовместимого объемообразующего эффекта при коррекции патологий нижних мочевых путей. Вместе с тем, несмотря на высокую биосовместимость исследуемых материалов в краткосрочной перспективе, вопросы их долгосрочной безопасности, риска фиброза и функциональных нарушений мочевого пузыря остаются открытыми и требуют дальнейшей клинической валидации.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Relevance</title><p>Relevance. Modern urological practice demands the search for and implementation of highly effective and biocompatible bulking materials capable of ensuring a stable clinical outcome with minimal risk of complications. The use of bulking agents is particularly significant in reconstructive and functional urology, where both aesthetic and functional outcomes are critically important. Currently, a variety of synthetic and biological materials are employed; however, each possesses certain limitations related to resorption, immunogenic reactions, and the risk of fibrosis. In this regard, the development and comparative analysis of new, combined approaches incorporating autologous components with high biocompatibility is a highly relevant research direction.</p></sec><sec><title>Aim</title><p>Aim. To conduct a comparative comprehensive evaluation of the efficacy and biocompatibility of various synthetic and autologous bulking agents used in urological practice, utilizing morphological and morphometric methods of analysis.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study involved 80 male Belgian rabbits, each receiving a submucosal injection of 0.3 mL of a bulking substrate into the bladder wall. All cases were divided into five groups. At 14 and 30 days post-injection, histological, histochemical, histomorphometric, and morphometric analyses were performed to objectively assess the inflammatory response, vascularization, cellular infiltration, degree of fibrosis, and transplant integrity.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The findings demonstrated that the combination of autologous lipotransplantation with platelet-rich plasma (PRP) exhibited more pronounced vascular network formation, reduced inflammation, and a more homogeneous distribution of transplanted tissue compared to other groups. This indicates high biocompatibility and the potential of this combination as an alternative to synthetic materials, particularly in cases requiring a long-lasting volumizing effect with minimal risk of complications.</p></sec><sec><title>Conclusion</title><p>Conclusion. The combination of PRP with autologous lipotransplantation, as well as the application of Vantris, appears to be among the most promising approaches for achieving a stable and biocompatible bulking effect in the correction of lower urinary tract pathologies. Nevertheless, despite the high short-term biocompatibility of the studied materials, questions regarding their long-term safety, the risk of fibrosis, and potential functional impairments of the bladder remain unresolved and warrant further clinical validation.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>липофилинг</kwd><kwd>PRP</kwd><kwd>уроимплант</kwd><kwd>филлер</kwd><kwd>PLLA</kwd><kwd>Vantris</kwd><kwd>пузырно-мочеточниковый рефлюкс</kwd><kwd>детская урология</kwd><kwd>мочевой пузырь</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lipofilling</kwd><kwd>PRP</kwd><kwd>uroimplant</kwd><kwd>filler</kwd><kwd>PLLA</kwd><kwd>Vantris</kwd><kwd>vesicoureteral reflux</kwd><kwd>pediatric urology</kwd><kwd>urinary bladder</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Конюший В.С., Пивень Н.В., Игловиков Н.Ю. Эффективность подуретральной инъекции объемообразующего препарата при лечении посткоитального цистита. Урология. 2021; 2: 156-162.</mixed-citation><mixed-citation xml:lang="en">Konjushij V.S., Piven' N.V., Iglovikov N.Ju. Jeffektivnost' poduretral'noj in#ekcii obemoobrazujushhego preparata pri lechenii postkoital'nogo cistita. Urologija. 2021; 2: 156-162.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Министра здравоохранения Республики Казахстан от 11 декабря 2020 года № ҚР ДСМ- 248/2020. https://adilet.zan.kz/rus/docs/V2000021772/info (дата обращения: 02.04.2022)</mixed-citation><mixed-citation xml:lang="en">Prikaz Ministra zdravoohranenija Respubliki Kazahstan ot 11 dekabrja 2020 goda № ҚR DSM-248/2020. https://adilet.zan.kz/rus/docs/V2000021772/info (data obrashhenija: 02.04.2022)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ и. о. Министра здравоохранения Республики Казахстан от 4 февраля 2021 года № ҚР ДСМ15. https://adilet.zan.kz/rus/docs/V1500011506 (дата обращения: 19.04.2022).</mixed-citation><mixed-citation xml:lang="en">Prikaz i. o. Ministra zdravoohranenija Respubliki Kazahstan ot 4 fevralja 2021 goda № ҚR DSM-15. https:// adilet.zan.kz/rus/docs/V1500011506 (data obrashhenija: 19.04.2022).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Allgoewer A., Mayer B. Sample size estimation for pilot animal experiments by using a Markov Chain Monte Carlo approach. Alternatives to Laboratory Animals. 2017; 45 (2): 83-90.</mixed-citation><mixed-citation xml:lang="en">Allgoewer A., Mayer B. Sample size estimation for pilot animal experiments by using a Markov Chain Monte Carlo approach. Alternatives to Laboratory Animals. 2017; 45 (2): 83-90.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Alshuaibi M., Zugail A.S., Lombion S., Beley S. New protocol in the treatment of Peyronie's disease by combining platelet-rich plasma, percutaneous needle tunneling, and penile modeling: Preliminary results. Fr. J. Urol. 2024; 34 (1): 102526. https://doi:10.1016/j.purol.2023.09.013</mixed-citation><mixed-citation xml:lang="en">Alshuaibi M., Zugail A.S., Lombion S., Beley S. New protocol in the treatment of Peyronie's disease by combining platelet-rich plasma, percutaneous needle tunneling, and penile modeling: Preliminary results. Fr. J. Urol. 2024; 34 (1): 102526. https://doi:10.1016/j.purol.2023.09.013</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Carey J.M., Chon J.K., Leach G.E. Urethrolysis with Martius labial fat pad graft for iatrogenic bladder outlet obstruction. Urology. 2003; 61(4): 21-25. https://doi:10.1016/s0090-4295(03)00117-1</mixed-citation><mixed-citation xml:lang="en">Carey J.M., Chon J.K., Leach G.E. Urethrolysis with Martius labial fat pad graft for iatrogenic bladder outlet obstruction. Urology. 2003; 61(4): 21-25. https://doi:10.1016/s0090-4295(03)00117-1</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Casavantes L., Lemperle G., Morales P. Penile girth enhancement with polymethylmethacrylate-based soft tissue fillers. Aesthetic Surgery Journal. 2016; 36 (8): 1414-1422.</mixed-citation><mixed-citation xml:lang="en">Casavantes L., Lemperle G., Morales P. Penile girth enhancement with polymethylmethacrylate-based soft tissue fillers. Aesthetic Surgery Journal. 2016; 36 (8): 1414-1422.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cirigliano L., Di Giovanni A., Giordano A., Dalterio C., La Rocca R., Palmieri A., et al. Hyaluronic acid injection for the management of Peyronie's disease. Journal of Sexual Medicine. 2022; 19 (11): S16. https://doi:10.1016/j.jsxm.2022.08.159</mixed-citation><mixed-citation xml:lang="en">Cirigliano L., Di Giovanni A., Giordano A., Dalterio C., La Rocca R., Palmieri A., et al. Hyaluronic acid injection for the management of Peyronie's disease. Journal of Sexual Medicine. 2022; 19 (11): S16. https://doi:10.1016/j.jsxm.2022.08.159</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Council of Europe. European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes. Strasbourg, 18.III.1986. https://rm.coe.int/168007a67b (дата обращения: 02.02.2023)</mixed-citation><mixed-citation xml:lang="en">Council of Europe. European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes. Strasbourg, 18.III.1986. https://rm.coe.int/168007a67b (дата обращения: 02.02.2023)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">El-Sharkawy H., Kantarci A., Deady J., et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. Journal of Periodontology. 2007; 78: 661669.</mixed-citation><mixed-citation xml:lang="en">El-Sharkawy H., Kantarci A., Deady J., et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. Journal of Periodontology. 2007; 78: 661669.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hersant B., Bouhassira J., SidAhmed-Mezi M., Vidal L., Keophiphath M., Chheangsun B. Should platelet-rich plasma be activated in fat grafts? An animal study. Journal of Plastic, Reconstructive &amp; Aesthetic Surgery. 2018; 71 (5): 681-690.</mixed-citation><mixed-citation xml:lang="en">Hersant B., Bouhassira J., SidAhmed-Mezi M., Vidal L., Keophiphath M., Chheangsun B. Should platelet-rich plasma be activated in fat grafts? An animal study. Journal of Plastic, Reconstructive &amp; Aesthetic Surgery. 2018; 71 (5): 681-690.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">International Organization for Standardization. Biological evaluation of medical devices – Part 6: Tests for local effects after implantation. ISO/DIS 10993-6:2024.</mixed-citation><mixed-citation xml:lang="en">International Organization for Standardization. Biological evaluation of medical devices – Part 6: Tests for local effects after implantation. ISO/DIS 10993-6:2024.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Liao H.T., Marra K.G., Rubin J.P. Application of platelet-rich plasma and platelet-rich fibrin in fat grafting: basic science and literature review. Tissue Engineering Part B: Reviews. 2014; 20: 267-276.</mixed-citation><mixed-citation xml:lang="en">Liao H.T., Marra K.G., Rubin J.P. Application of platelet-rich plasma and platelet-rich fibrin in fat grafting: basic science and literature review. Tissue Engineering Part B: Reviews. 2014; 20: 267-276.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Matthews R.D., Christensen J.P., Canning D.A. Persistence of autologous free fat transplant in bladder submucosa of rats. Journal of Urology. 1994; 152 (2): 819-821. https://doi:10.1016/s0022-5347(17)32719-2</mixed-citation><mixed-citation xml:lang="en">Matthews R.D., Christensen J.P., Canning D.A. Persistence of autologous free fat transplant in bladder submucosa of rats. Journal of Urology. 1994; 152 (2): 819-821. https://doi:10.1016/s0022-5347(17)32719-2</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Pak I., Askarov M., Kissamedenov N., Klyuyev D., Kamyshanskiy Y. Experimental study on clinical and morphological determination of the optimal cannula diameter for lipoaspirate harvest from rabbit inguinal fat pad. Journal of Applied Biomedicine. 2023; 21 (2): 99-105. https://doi:10.32725/jab.2023.011</mixed-citation><mixed-citation xml:lang="en">Pak I., Askarov M., Kissamedenov N., Klyuyev D., Kamyshanskiy Y. Experimental study on clinical and morphological determination of the optimal cannula diameter for lipoaspirate harvest from rabbit inguinal fat pad. Journal of Applied Biomedicine. 2023; 21 (2): 99-105. https:// doi:10.32725/jab.2023.011</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Santiago González de Garibay A.M., Castro Morrondo J., Castillo Jimeno J.M., Sánchez Robles I., Sebastián Borruel J.L. Inyección endoscópica de tejido graso autólogo en el tratamiento de la incontinencia femenina. Archivos Españoles de Urología. 1989; 42 (2): 143-146.</mixed-citation><mixed-citation xml:lang="en">Santiago González de Garibay A.M., Castro Morrondo J., Castillo Jimeno J.M., Sánchez Robles I., Sebastián Borruel J.L. Inyección endoscópica de tejido graso autólogo en el tratamiento de la incontinencia femenina. Archivos Españoles de Urología. 1989; 42 (2): 143-146.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Vasudeva P., Yadav S., Sinha S., Raheja A., Kumar N., Patel A. Autologous versus synthetic midurethral transobturator sling: A systematic review and meta-analysis of outcomes. Neurourology and Urodynamics. 2024; 43 (8): 2017-2029. https://doi:10.1002/nau.25527</mixed-citation><mixed-citation xml:lang="en">Vasudeva P., Yadav S., Sinha S., Raheja A., Kumar N., Patel A. Autologous versus synthetic midurethral transobturator sling: A systematic review and meta-analysis of outcomes. Neurourology and Urodynamics. 2024; 43 (8): 2017-2029. https://doi:10.1002/nau.25527</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Xiong B.J., Tan Q.W., Chen Y.J., Zhang Y., Zhang D., Tang S.L., Zhang S., Lv Q. The effects of platelet-rich plasma and adipose-derived stem cells on neovascularization and fat graft survival. Aesthetic Plastic Surgery. 2018; 42 (1): 1-8. https://doi:10.1007/s00266-017-1062-1</mixed-citation><mixed-citation xml:lang="en">Xiong B.J., Tan Q.W., Chen Y.J., Zhang Y., Zhang D., Tang S.L., Zhang S., Lv Q. The effects of platelet-rich plasma and adipose-derived stem cells on neovascularization and fat graft survival. Aesthetic Plastic Surgery. 2018; 42 (1): 1-8. https://doi:10.1007/s00266-017-1062-1</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
